A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis - Phatak, Pradyumna; Brissot, Pierre; Wurster, Mark; Adams, Paul C; Bonkovsky, Herbert L.; Gross, John; Malfertheiner, Peter; McLaren, Gordon D.; Niederau, Claus; Piperno, Alberto; Powell, Lawrie W.; Russo, Mark W.; et al. (Hepatology, 2010)
Gesehen am 03.05.2023